A detailed history of Ghp Investment Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ghp Investment Advisors, Inc. holds 6,115 shares of ABBV stock, worth $1.04 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,115
Previous 5,801 5.41%
Holding current value
$1.04 Million
Previous $994,000 21.43%
% of portfolio
0.06%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $51,445 - $62,589
314 Added 5.41%
6,115 $1.21 Million
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $13,931 - $16,268
90 Added 1.58%
5,801 $994,000
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $7,991 - $9,105
-50 Reduced 0.87%
5,711 $1.04 Million
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $72,377 - $81,514
-526 Reduced 8.37%
5,761 $892,000
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $55,840 - $64,643
418 Added 7.12%
6,287 $937,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $29,947 - $37,267
226 Added 4.0%
5,869 $790,000
Q1 2023

Apr 21, 2023

SELL
$144.61 - $166.54 $35,863 - $41,301
-248 Reduced 4.21%
5,643 $899,000
Q4 2022

Feb 16, 2023

BUY
$138.31 - $165.87 $6,915 - $8,293
50 Added 0.86%
5,891 $952,000
Q3 2022

Oct 28, 2022

SELL
$134.21 - $153.93 $134 - $153
-1 Reduced 0.02%
5,841 $784,000
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $49,267 - $62,635
-358 Reduced 5.77%
5,842 $895,000
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $6,994 - $8,678
-53 Reduced 0.85%
6,200 $1.01 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $116,776 - $147,755
-1,087 Reduced 14.81%
6,253 $847,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $28,728 - $32,610
-270 Reduced 3.55%
7,340 $792,000
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $172,018 - $191,638
1,635 Added 27.36%
7,610 $857,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $21,483 - $23,650
210 Added 3.64%
5,975 $647,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $724 - $978
-9 Reduced 0.16%
5,765 $618,000
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $5,498 - $6,453
-64 Reduced 1.1%
5,774 $506,000
Q2 2020

Aug 06, 2020

SELL
$73.37 - $98.18 $173,520 - $232,195
-2,365 Reduced 28.83%
5,838 $573,000
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $147,834 - $224,134
2,292 Added 38.78%
8,203 $625,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $11,396 - $14,259
158 Added 2.75%
5,911 $523,000
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $6,046 - $7,269
-96 Reduced 1.64%
5,753 $436,000
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $591 - $755
9 Added 0.15%
5,849 $425,000
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $8,871 - $10,440
115 Added 2.01%
5,840 $471,000
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $544 - $672
7 Added 0.12%
5,725 $528,000
Q3 2018

Oct 17, 2018

SELL
$88.91 - $98.84 $57,969 - $64,443
-652 Reduced 10.24%
5,718 $541,000
Q2 2018

Aug 17, 2018

BUY
$89.78 - $106.23 $35,912 - $42,492
400 Added 6.7%
6,370 $590,000
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $40,749 - $44,685
455 Added 8.25%
5,970 $577,000
Q3 2017

Nov 03, 2017

BUY
$69.85 - $89.22 $385,222 - $492,048
5,515
5,515 $490,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ghp Investment Advisors, Inc. Portfolio

Follow Ghp Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghp Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ghp Investment Advisors, Inc. with notifications on news.